The microbiota in the nose and upper throat likely contains biomarkers for assessing how sick an individual infected with SARS-CoV-2 may get and for developing new treatment strategies to improve their outcome, researchers say.
Click here for original story, Nasal microbiota holds clues to who will develop symptoms from novel coronavirus
Source: ScienceDaily